GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ReNeuron Group PLC (OTCPK:RNUGF) » Definitions » Short Interest

RNUGF (ReNeuron Group) Short Interest


View and export this data going back to 2006. Start your Free Trial

What is ReNeuron Group Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data is no longer available on GuruFocus website.


Competitive Comparison of ReNeuron Group's Short Interest

For the Biotechnology subindustry, ReNeuron Group's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


ReNeuron Group's Short Interest Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, ReNeuron Group's Short Interest distribution charts can be found below:

* The bar in red indicates where ReNeuron Group's Short Interest falls into.


;
;

ReNeuron Group Business Description

Traded in Other Exchanges
N/A
Address
Pencoed Business Park, Pencoed, Bridgend, GBR, CF35 5HY
ReNeuron Group PLC is engaged in the field of biotechnology. Its core activities include the research and clinical development of cell-based therapeutics. The company product pipeline includes the human retinal progenitor cell line (hRPC) and CTX neural cell line. It derives revenue from UK and U.S. The company is mainly focusing on the treatment of stroke disability, inherited retinal diseases, and cancer.

ReNeuron Group Headlines

From GuruFocus

Edison Issues Outlook on ReNeuron Group (RENE)

By ACCESSWIRE ACCESSWIRE 08-26-2020

ReNeuron Expands Exosome IP Portfolio with Key Patent Grants

By PRNewswire PRNewswire 07-16-2019

ReNeuron Announces Exosome Research Collaboration

By PRNewswire PRNewswire 04-07-2020

Half Year 2022 ReNeuron Group PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024

ReNeuron Provides Program and Regulatory Approvals Update

By PRNewswire PRNewswire 06-17-2020

ReNeuron Signs New Exosome Research Collaboration

By PRNewswire PRNewswire 06-25-2020

Full Year 2020 ReNeuron Group PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024

Full Year 2022 ReNeuron Group PLC Earnings Call Transcript

By GuruFocus Research 02-14-2024